The AHNS acknowledges generous support of this educational webinar series from Intuitive Surgical
Webinar 1 – Patient Selection & Complications
|Moderators:||Neil Gross, MD, FACS; MD Anderson Cancer Center|
|Barry Wenig, MD; University of Illinois at Chicago|
|Panelists:||Meghan Turner, MD; West Virginia University Medical Center|
|David Cognetti, MD; Thomas Jefferson University Hospital|
|Mihir Patel, MD; Emory University Hospital Midtown|
Description: Patient selection is key to the successful application of TORS. Join this expert panel discussion to explore common approaches to selecting patients for TORS as well as techniques for avoiding complications.
|Moderators:||Katie Van Abel, MD; Mayo Clinic|
|Chris Holsinger, MD; Stanford University|
|Panelists:||Guiseppe Spriano, MD; H&N Surgery, Humanitas University, Milano, IT|
|Mererid Evans, MD; Oncology; University of Cardiff, Wales, UK|
|Joaquin Garcia, MD; Pathology The Mayo Clinic, MN|
|Jason Chan, MD; The Chinese University of Hong Kong|
Description: Controversies in managing patients with oropharyngeal cancer with TORS and neck dissection are discussed in this multidisciplinary panel. What are pre-operative indications for the ideal TORS candidate? Which pre-treatment factors should nudge patients toward chemoradiation? Are there objective criteria to advise patients? In particular, the panel will discuss the impact of extranodal extension and margin assessment on post-operative adjuvant therapy.
|Moderators:||Uma Duvvuri, MD, PhD – University of Pittsburgh Medical Center|
|Ranee Mehra, MD; Oncology; University of Maryland Medical Center|
|Panelists:||Robert Ferris, MD, PhD – UPMC Hillman Cancer Center|
|Daniel C. Ma, MD – Mayo Clinic|
|David Palma, MD – London Health Sciences Centre|
Description: The incidence of HPV-associated oropharyngeal cancer is rapidly increasing. Given the oncologic outcomes for this disease, there is great interest in rationally de-escalating treatment for some patients. The panelists on this webinar will present current data from clinical trials that describe options for treatment de-escalation. The panel discussion will present real world cases, and provide the audience with an opportunity to understand the application and limitations of these data in the management of patients with oropharyngeal cancer.
|Moderators:||Jeremy Richmon, MD, FACS; Massachusetts Eye & Ear|
|Panelists:||Daniel Clayburgh, MD, PhD; Oregon Health & Science University|
|Andrew J. Holcomb, MD; Nebraska Methodist Medical Center / Creighton University|
|Allison Hollman, MS, CCC-SLP; Mass General Cancer Center|
|Carol M Lewis, MD, MPH; UT MD Anderson Cancer Center|
Description: Despite transoral robotic surgery (TORS) being a well-accepted tool in the management of patients with oropharyngeal cancer, perioperative care pathways vary considerably from one institution to another. Growing utilization of enhanced recovery after surgery (ERAS) protocols have yielded compelling data across multiple disciplines, albeit not yet for TORS. In this panel, we will discuss the current landscape of perioperative care pathways for the TORS patient including pre-operative counseling and education, management of anticoagulation, ERAS protocols, pain control, speech language pathology involvement and swallow initiation.